776 related articles for article (PubMed ID: 9794568)
1. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
[TBL] [Abstract][Full Text] [Related]
6. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
[TBL] [Abstract][Full Text] [Related]
7. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
8. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
9. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients.
Steiner RW; Ziegler M; Halasz NA; Catherwood BD; Manolagas S; Deftos LJ
Transplantation; 1993 Oct; 56(4):843-6. PubMed ID: 8212205
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
Barros X; Rodríguez NY; Fuster D; Rodas L; Esforzado N; Mazza A; Rubello D; Campos F; Tapias A; Torregrosa JV
J Nephrol; 2016 Oct; 29(5):703-9. PubMed ID: 26454858
[TBL] [Abstract][Full Text] [Related]
11. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
13. Calcium and phosphorus metabolism in stable renal transplant recipients.
Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
Sella S; Bonfante L; Fusaro M; Neri F; Plebani M; Zaninotto M; Aghi A; Innico G; Tripepi G; Michielin A; Prandini T; Calò LA; Giannini S
Clin Chem Lab Med; 2020 May; 59(2):343-351. PubMed ID: 32374278
[TBL] [Abstract][Full Text] [Related]
15. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
[TBL] [Abstract][Full Text] [Related]
17. Are plasma 1,25-dihydroxyvitamin D3 concentrations appropriate after successful kidney transplantation?
Caravaca F; Fernández MA; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998; 13 Suppl 3():91-3. PubMed ID: 9568829
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
Findling JW; Adams ND; Lemann J; Gray RW; Thomas CJ; Tyrrell JB
J Clin Endocrinol Metab; 1982 May; 54(5):1039-44. PubMed ID: 6977549
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
20. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
